Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease (Q36704499)
Jump to navigation
Jump to search
scientific article published on 5 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease |
scientific article published on 5 November 2015 |
Statements
1 reference
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease (English)
1 reference
Rosario Pivonello
1 reference
Maria Fleseriu
1 reference
Jacques Young
1 reference
Amir H Hamrahian
1 reference
Mark E Molitch
1 reference
Chikara Shimizu
1 reference
Tomoaki Tanaka
1 reference
Akira Shimatsu
1 reference
Tracy White
1 reference
Annie Hilliard
1 reference
Chuan Tian
1 reference
Nicholas Sauter
1 reference
Beverly M K Biller
1 reference
Xavier Bertagna
1 reference
5 November 2015
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference